Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results from a prospective international real-world registry of sutureless aortic bioprosthesis by a minimally invasive approach.

Frontiers in cardiovascular medicine·2026
Same author

Myval Octacor and Octapro T<i>rans</i>-Catheter Heart Valves in Patients with Severe Pure Non Calcified Native Aortic Regurgitation.

International journal of cardiology. Heart & vasculature·2026
Same author

Direct oral anticoagulants versus vitamin K antagonists after heart valve bioprosthetic replacement or repair: A systematic review and meta-analysis.

Archives of cardiovascular diseases·2026
Same author

Artificial intelligence in the diagnosis and management planning of bicuspid aortic valvular disease: a case series.

European heart journal. Case reports·2025
Same author

Prognostic impact of small size sutureless prostheses: results for 241 patients from an international registry.

Journal of cardiothoracic surgery·2025
Same author

Expert Consensus on Clinical Application of Implantable Biventricular Assist Devices.

Current medical science·2025

Related Experiment Video

Updated: May 4, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.3K

Pump-assisted beating heart surgery.

Mattia Glauber1, Andrea Farneti, Stefano Bevilacqua

  • 1CNR Institute of Clinical Physiology 'G. Pasquinucci' Hospital, Via Aurelia Sud, 54100 Massa, Italy.

Multimedia Manual of Cardiothoracic Surgery : MMCTS
|January 14, 2014
PubMed
Summary
This summary is machine-generated.

This study presents minimally invasive cardiac surgery for myocardial revascularization using beating heart techniques and advanced pump-assisted extracorporeal circulation. It details the procedure and its clinical physiological aspects.

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.9K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K

Related Experiment Videos

Last Updated: May 4, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.3K
Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.9K
Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Cardiac Surgery
  • Cardiopulmonary Bypass

Background:

  • Ischemized myocardium requires effective revascularization strategies.
  • Traditional cardiopulmonary bypass can be associated with complications.
  • Advancements in technology enable less invasive surgical approaches.

Purpose of the Study:

  • To present the technique of myocardial revascularization using a beating heart approach.
  • To highlight modern mini extracorporeal circulation (MECC) and beating heart surgery devices.
  • To describe the clinical physiological aspects of this revascularization method.

Main Methods:

  • Beating heart surgery technique for myocardial revascularization.
  • Utilizing pump-assisted extracorporeal circulation, specifically mini extracorporeal circulation (MECC).
  • Detailed presentation of surgical devices and procedural steps.

Main Results:

  • Successful revascularization of ischemized myocardium was achieved.
  • The beating heart technique with MECC demonstrated feasibility.
  • Clinical physiological data and bibliographical references were provided.

Conclusions:

  • Minimally invasive myocardial revascularization using beating heart technique and MECC is a viable option.
  • Modern devices enhance the safety and efficacy of this approach.
  • Further clinical data supports the application of this technique.